The combined status of ATM and p53 link tumor development with therapeutic responseHai Jiang, Michael T. Hemann|Genes & Development|2009Cited by 301
A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responsesEric H. Bent, Michael T. Hemann|Genes & Development|2016Cited by 167
Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapyEric H. Bent, Michael T. Hemann|Nature Communications|2021Cited by 148
Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to TemozolomideJosé L. McFaline‐Figueroa, Leona D. Samson, Christian Braun et al.|Cancer Research|2015Cited by 124
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screeningAzucena Ramos, Michael T. Hemann|Nature Communications|2023Cited by 24